Journal
SCIENCE OF THE TOTAL ENVIRONMENT
Volume 599, Issue -, Pages 612-626Publisher
ELSEVIER
DOI: 10.1016/j.scitotenv.2017.03.253
Keywords
Cytostatic drugs; Advanced oxidation process; Photocatalytic membrane reactor; Hospital wastewater treatment; Pharmaceutical compounds
Categories
Funding
- INNO INDIGO Partnership Programme through TREAT-AFTER-TOO project (INNO Indigo project TREAT-AFTER-TOO)
Ask authors/readers for more resources
The potential of photocatalytic membrane reactors (PMR) to degrade cytostatic drugs is presented in this work as an emerging technology for wastewater treatment. Cytostatic drugs are pharmaceutical compounds (PhCs) commonly used in cancer treatment. Such compounds and their metabolites, as well as their degraded by-products have genotoxic and mutagenic effects. A major challenge of cytostatic removal stands in the fact that most drugs are delivered to ambulant patients leading to diluted concentration in the municipal waste. Therefore safe strategies should be developed in order to collect and degrade the micro-pollutants using appropriate treatment technologies. Degradation of cytostatic compounds can be achieved with different conventional processes such as chemical oxidation, photolysis or photocatalysis but the treatment performances obtained are lower than the ones observed with slurry PMRs. Therefore the reasons why slurry PMRs may be considered as the next generation technology will be discussed in this work together with the limitations related to the mechanical abrasion of polymeric and ceramic membranes, catalyst suspension and interferences with the water matrix. Furthermore key recommendations are presented in order to develop a renewable energy powered water treatment based on long lifetime materials. (C) 2017 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available